Qube Research & Technologies (QRT)’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$60.5K Sell
11,100
-300
-3% -$1.68K ﹤0.01% 3148
2025
Q4
$79.8K Buy
+11,400
New +$89.3K ﹤0.01% 3224
2023
Q4
Sell
-1,100
Closed -$20.4K 4721
2023
Q3
$20.4K Buy
+1,100
New +$25.7K ﹤0.01% 3144

Other funds holding TDOC

Qube Research & Technologies (QRT)'s TDOC Position: Q3 2025 in Review

Qube Research & Technologies (QRT) sold out of Teladoc Health (TDOC) in Q3 2025, closing a stake of 63,424 shares — an estimated $552K sold.

Qube Research & Technologies (QRT) first reported a position in TDOC in Q1 2020 and held it in 14 quarters. The position peaked at $30.5M in Q3 2023. 355 funds tracked by Wall St. Rank hold TDOC as of Q3 2025.

  • Qube Research & Technologies (QRT) reported no remaining Teladoc Health position as of Q3 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 63,424 Teladoc Health shares in Q3 2025, an estimated $552K.
  • Qube Research & Technologies (QRT) first reported a position in Teladoc Health in Q1 2020 and held it in 14 quarters.
  • Qube Research & Technologies (QRT)'s Teladoc Health position peaked at $30.5M in Q3 2023.
  • 355 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2025, filed 14 Nov 2025.